Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration

Seongho Ryu1, Kevin McDonnell, Hyejin Choi

  • 1Department of Cardiothoracic Surgery, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA.

Cancer Cell
|January 19, 2013
PubMed

Insights

MicroRNA-708 (miR-708) suppresses breast cancer metastasis by targeting neuronatin, reducing cell migration and invasion. Lower miR-708 levels correlate with metastasis in patients, indicating its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Metastatic breast cancer remains a leading cause of cancer-related mortality.
  • Understanding the molecular mechanisms driving metastasis is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the role of microRNA-708 (miR-708) in breast cancer metastasis.
  • To elucidate the regulatory mechanisms and downstream targets of miR-708 in the context of metastasis.

Main Methods:

  • Analysis of miR-708 expression in breast cancer tissues.
  • Investigating the role of Polycomb Repressor Complex 2 (PRC2) in miR-708 repression.
  • Identifying miR-708 targets and their functional consequences on cell migration and metastasis.
  • In vitro and in vivo models of breast cancer metastasis.

Main Results:

  • miR-708 is transcriptionally repressed by PRC2-mediated H3K27 trimethylation in metastatic breast cancer.
  • miR-708 directly targets neuronatin, decreasing intracellular calcium levels.
  • Reduced neuronatin levels impair activation of ERK and FAK, leading to decreased cell migration and metastasis.
  • Ectopic expression of miR-708 suppressed metastasis, while neuronatin overexpression rescued these defects.
  • miR-708 expression is significantly decreased in lymph node and distal metastases of breast cancer patients.

Conclusions:

  • miR-708 acts as a metastasis suppressor in breast cancer by regulating the neuronatin-calcium-ERK/FAK pathway.
  • PRC2-mediated repression of miR-708 contributes to breast cancer progression and metastasis.
  • miR-708 represents a potential therapeutic target for combating metastatic breast cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...